Another target of anti-cancer therapy
A drug that selectively suppresses the activity of the histone – 11 deathylase enzyme will be an effective antitumor drug without affecting normally functioning cells.
08.11.2012A drug that selectively suppresses the activity of the histone – 11 deathylase enzyme will be an effective antitumor drug without affecting normally functioning cells.
08.11.2012Many probiotic bacteria added to foods such as yogurt are unable to reach the intestines. Most of them die in the stomach. Maybe it's worth trying to use a protective coating?
08.11.2012All heart attack patients who received autologous stem cell therapy in phase I clinical trials showed significant improvement in cardiac function. No side effects of cell therapy were noted.
07.11.2012In the UK, some insurance companies have started to prepare pension programs based on the expectation that the client can live up to 120-125 years.
07.11.2012Biologists from the University of Rochester have found out how a blind digger fights cancer. The mechanism they established differs from what was discovered three years ago in another long–lived and cancer-resistant species of blind - a naked digger.
07.11.2012A blood test will predict the aggressiveness of atherosclerosis, osteoporosis and cancer by the activity of cathepsins – enzymes that destroy extracellular matrix proteins.
07.11.2012Blocking the activity of the enzyme hyaluronidase stimulates the restoration of the myelin sheath of nerve fibers, which is destroyed in multiple sclerosis and other neurological diseases.
07.11.2012The method of early cancer diagnosis is based on the detection of the gammaH2AX protein produced in cells in response to DNA damage. It is believed that the appearance of this protein is one of the first steps on the cell's path to malignancy.
07.11.2012In the brains of people genetically predisposed to the development of Alzheimer's disease, biomarkers of the disease can be detected more than 20 years before the first symptoms appear.
07.11.2012"In vitro" progenitor cells of neuroglia quickly stop dividing, and there are too few myelinating oligodendrocytes suitable for cell therapy. Scientists have managed to overcome this barrier.
06.11.2012Mice with the Huntington's disease model after the introduction of the synthetic mitochondrial antioxidant XJB-5-131 looked and behaved like healthy animals.
06.11.2012Mice with "humanized" livers will help in drug development
06.11.2012Hereditary longevity is associated with low levels of vitamin D in the body. In addition, the descendants of centenarians were less likely to have a variation in the CYP2R1 gene associated with a predisposition to the accumulation of vitamin D.
06.11.2012Injection of stem cells stored in a cryobank, giving rise to sperm cells, allows restoring male fertility lost during antitumor therapy.
06.11.2012The vaccine against amphetamine will deprive whole armies of ordinary hardworking drug dealers around the world of a piece of bread.
02.11.2012The third phase of clinical trials of the anti-cancer drug alemtuzumab confirmed its greater effectiveness compared to the standard interferon beta-1a used in the treatment of multiple sclerosis.
02.11.2012Drugs used to treat such common pathologies as diabetes, hypertension and skin diseases may find use in the treatment of Alzheimer's disease over the next 10 years.
02.11.2012At the end of the second phase of the 1000 Genomes project, an international group of researchers published the results of the analysis of the complete sequencing of the genomes of 1,092 representatives of 14 different populations.
02.11.2012Alexey Ryazanov, Professor of Pharmacology at the R.V. Johnson Medical School at the University of Medicine and Dentistry of New Jersey, talks about how an experiment is underway to find drugs to prolong life.
02.11.2012Scientists from the Carnegie Institute have uncovered a mechanism integrating signaling pathways involved in the process of self–renewal of embryonic stem cells, and found a key link in this process - the Utf1 protein.
02.11.2012You can write to the editor at:
vm@vechnayamolodost.ruThe editors of Eternal Youth are preparing a useful and interesting mailing list. You can get it if you leave your mail.